Transplant Diagnostics Market Report include on MarketReseacrhFuture.com with exhaustive Study. The report aims to provide an overview of Transplant Diagnostics Market Report. The report provides key statistics on the market status. Global Forecast till 2023.
Global Transplant Diagnostics Market – Overview
Global transplant diagnostics market is expected to grow at a CAGR of 7.2% during forecasted period 2017-2023. Antibody-mediated refusal of organ allografts is difficult to treat as barriers following allotransplantation. Enhanced diagnostics has permitted better detection and specificity-determination of antibodies precise for a donor Human Leukocyte Antigens (HLA).
Get Exclusive Sample Copy of Transplant Diagnostics Market spread across 80 Premium Pages, 10+ and Supported with Full TOC, is Available @ https://www.marketresearchfuture.com/sample_request/1324 .
Nevertheless, antibodies which are also against non-HLA antigens are of importance for graft function. We have established a novel crossmatch test that simplifies detection of donor-specific non-HLA particular antibodies prior to transplantation. Doctors and expert physicians are presently refining this test which allows detection of complement-fixing non-HLA antibodies. Additionally, studies are going on to assess the occurrence of non-HLA specific antibodies in kidney graft inheritors post-transplant as well as at the time of rejection.
A substantial problem in clinical transplantation is the lack of donor tissue/organs for transplantation. One of the possible solutions to this problem is the use of tissues/organs/ cells from animals for transplantation to man, which is also known as xenotransplantation. Because xenografts are dynamically rejected, studies on the reasons for this rejection are essential. In particular specialists are interested in evaluating co-stimulation blockade as a means of undertaking long-term pancreatic islet xenograft survival.
Key Players for Global Transplant Diagnostics Market:
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US).
Global Transplant Diagnostics Market – Competitive Analysis
Thermo Fisher Scientific Acquires Linkage Bio: on July 2017 Thermo Fisher Scientific confirmed the company’s acquisition of Linkage Biosciences for an undisclosed amount, as a result of this acquisition Linkage Biosciences is now a part of Thermo Fisher’s transplant diagnostics business. The company based in South San Francisco, California. Benefits involved from the acquisition include a broader and deeper range of products, a continued commitment to innovation, and expanded support globally.
The business is extremely complementary to the company’s One Lambda tests, which regulate the compatibility of donors and recipients pre- and post-transplant. This acquisition further expands Thermo Fisher’s commitment of improving transplant patients’ quality of life over innovative high-quality products for the clinical and research segments of the transplant community.
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US) are some of the major players in the Global Transplant Diagnostics Market.
Segmentation:
Global Transplant Diagnostics Market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, and kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centres, research laboratories and other.
TOC of Transplant Diagnostics Market Research Report- Global Forecast Till 2023
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS
TOC CONTINUED…!
Key Questions Answered In This Report:
What will the market size and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/1324 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312